12don MSNOpinion
You Say The Supreme Court Isn’t Partisan? Look in the Shadow
This article is part of TPM Cafe, TPM’s home for opinion and news analysis. As the Supreme Court wrapped ...
DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...
WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could have broad consequences for generic ...
On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up ...
The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
A systematic review found that FDA leaders historically accepted recommendations made by the agency’s scientists regarding mifepristone.
Shares of Bayer AG BAYRY gained 6.41% on Jan. 19, after the company announced that the Supreme Court agreed to review the ...
At a Glance The FDA reversed its 2022 NMN ban in September 2025, allowing the $500 million ingredient back on the market ...
FDA upgrades nationwide cheese recall to highest danger level after listeria-causing bacteria found in these products.
The fate of a Texas law that makes it a crime to enter the country without authorization could hinge on who has the right to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results